RIOX2 and glioblastoma: Our study shows that knockdown of MINA53 sensitized glioblastoma cells to the genotoxic drug Doxorubicin, which gives more support for gene and drug combination therapeutics and may help to further improve the efficacy of glioblastoma interstitial chemotherapy.